David Loewenstein, Ph.D., ABPP-CN
Dr. Loewenstein is a Project Leader for the ADRC. He is also Director of Research and Neuropsychological Laboratories at The Wien Center for Alzheimer’s Disease and Memory Disorders at Mount Sinai Medical Center, Miami Beach, FL.
He is Principal Investigator on several large NIH and state funded grants and has a number of ongoing longitudinal investigations with new cognitive instruments developed in his laboratory. The Direct Assessment of Functional status Scale (DAFS) was one of the first performance-based scales for Alzheimer’s disease and has been translated into multiple languages. The Semantic Interference Test (SIT) and the Loewenstein- Acevedo Scales for Semantic Interference (LASSI) have shown considerable promise in the early detection and prediction of progression in patients with early Alzheimer’s disease and other neurodegenerative disorders.